Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell

Placenta

Volumn 21, Issue 4, 2000, Pages 388-393

  Asahina, T ^a   Kobayashi, T ^a   Okada, Y ^a   Goto, J ^a   Terao, T ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13; CYTOKERATIN; PROTEIN SUBUNIT;

ADULT; ARTICLE; BLOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTROPHOBLAST; FEMALE; FETUS DEATH; FIRST TRIMESTER PREGNANCY; HUMAN; IMMUNOHISTOCHEMISTRY; IMPLANTATION; MATERNAL BLOOD; PRIORITY JOURNAL; SPONTANEOUS ABORTION;

EID: 0034129972     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.1999.0489     Document Type: Article

References (18)

1. Aplin JD, Campbell S. An immunofluorescence study of extracellular matrix associated with cytotrophoblast of the chorion leave. Placenta. 6:1985;469-479.
2. Asahina T, Kobayashi T, Okada Y, Itoh M, Yamashita M, Inamoto Y, Terao T. Studies on the role of adhesive proteins in maintaining pregnancy. Horm Res. 50:1998;37-45.
3. Babawale MO, Noorden SV, Pignatelli M, Stamp GWH, Elder MG, Sullivan MHF. Morphological interactions of human first trimester placental villi cocultured with decidual explants. Hum Reprod. 11:1996;444-450.
4. Beck E, Duckert F, Ernst M. The influence of fibrin stabilizing factor on the growth of fibroblasts in vitro and wound healing. Thromb Diath Haemorrh. 6:1961;485-492.
5. Boda Z, Pfliegler G, Muszbek L, Tóth A, Àdány R, Hársfalvi J, Papp Z, Tornai I, Rak K. Congenital factor XIII deficiency with multiple benign breast tumours and successful pregnancy with substitutive therapy. Haemostasis. 19:1989;348-352.
6. Bruhn HD, Pohl J. Growth regulation of fibroblasts by thrombin, factor XIII and fibronectin. Klinishe Wochenschrift. 59:1981;145-146.
7. Duckert F, Jung E, Shmerling DH. A hitherto undiscribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thrombos Diathes Haemorrh. 5:1960;179-186.
8. Earl U, Morrison L, Gray C, Bulmer N. Proteinase and proteinase inhibitor localization in the human placenta. Int J Pathol. 8:1989;114-124.
9. Fisher S, Rikover M, Naor S. Factor 13 deficiency with severe hemorrhage diathesis. Blood. 28:1966;34-39.
10. Frank HG, Malekzadeh F, Kertschanska S, Crescimanno C, Castellucci M, Lang I, Desoye G, Kaufmann P. Immunohistochemistry of two different types of placental fibrinoid. Acta Anat. 150:1994;55-68.
11. Hayano Y, Imai N, Karasawa T. Studies on the physiological changes of blood coagulation factor XIII during pregnancy and their significance. Acta Obstet Gynaec Jap. 34:1982;469-477.
12. Ikkala E, Myllylä G, Nevanlinna HR. Transfusion therapy in factor XIII (F.S.F.) deficiency. Scand J Haematol. 1:1964;308-312.
13. Kobayashi T, Terao T, Kojima T, Takamatsu J, Kamiya T, Saito H. Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery. Gynecol Obstet Invest. 29:1990;235-238.
14. Kobayashi T, Asahina T, Okada Y, Terao T. Studies on the localization of adhesive proteins associated with the development of extravillous cytotrophoblast. Trophoblast Research. 13:1999;35-53.
15. Lorand L, Losowsky MS, Miloszewski KJ. Human factor XIII: fibrin stabilizing factor. Prog Hemost Thromb. 5:1980;245-290.
16. Rodeghiero F, Castaman GC, Di Bona E, Ruggeri M, Dini E. Successful pregnancy in a woman with congenital factor XIII deficiency treated with substitutive therapy. Blut. 55:1987;45-48.
17. Ueyama M, Urayama T. The role of factor XIII in fibroblast proliferation. Japan J Exp Med. 48:1978;135-142.
18. Vicovac L, Aplin JD. Epithelial-mesenchymal transition during trophoblast differentiation. Acta Anat. 156:1996;202-216.